vs
eXp World Holdings, Inc.（EXPI）与百利高（PRGO）财务数据对比。点击上方公司名可切换其他公司
eXp World Holdings, Inc.的季度营收约是百利高的1.1倍（$1.2B vs $1.1B），eXp World Holdings, Inc.净利率更高（-1.1% vs -127.8%，领先126.7%），eXp World Holdings, Inc.同比增速更快（8.5% vs -2.5%），百利高自由现金流更多（$148.6M vs $11.9M），过去两年eXp World Holdings, Inc.的营收复合增速更高（12.4% vs 1.3%）
eXp World Holdings是全球云原生房地产服务提供商，运营eXp Realty经纪网络，依托沉浸式3D虚拟园区支持代理人协作与日常运营，业务覆盖全球20余个国家的住宅及商业地产市场，同时提供按揭贷款、产权保险、从业者职业培训等配套服务。
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
EXPI vs PRGO — 直观对比
营收规模更大
EXPI
是对方的1.1倍
$1.1B
营收增速更快
EXPI
高出11.0%
-2.5%
净利率更高
EXPI
高出126.7%
-127.8%
自由现金流更多
PRGO
多$136.7M
$11.9M
两年增速更快
EXPI
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $1.1B |
| 净利润 | $-12.9M | $-1.4B |
| 毛利率 | — | 32.6% |
| 营业利润率 | -1.1% | -116.0% |
| 净利率 | -1.1% | -127.8% |
| 营收同比 | 8.5% | -2.5% |
| 净利润同比 | -35.7% | -3093.9% |
| 每股收益（稀释后） | $-0.08 | $-10.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXPIPRGO
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | $1.3B | $1.0B | ||
| Q2 25 | $1.3B | $1.1B | ||
| Q1 25 | $954.9M | $1.0B | ||
| Q4 24 | $1.1B | $1.1B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.3B | $1.1B | ||
| Q1 24 | $943.1M | $1.1B |
净利润EXPIPRGO
| Q4 25 | $-12.9M | $-1.4B | ||
| Q3 25 | $3.5M | $7.5M | ||
| Q2 25 | $-2.3M | $-8.4M | ||
| Q1 25 | $-11.0M | $-6.4M | ||
| Q4 24 | $-9.5M | $-44.4M | ||
| Q3 24 | $-8.5M | $-21.0M | ||
| Q2 24 | $12.4M | $-108.4M | ||
| Q1 24 | $-15.6M | $2.0M |
毛利率EXPIPRGO
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | 99.9% | 37.2% | ||
| Q2 24 | 99.9% | 37.0% | ||
| Q1 24 | — | 33.1% |
营业利润率EXPIPRGO
| Q4 25 | -1.1% | -116.0% | ||
| Q3 25 | 0.3% | 7.0% | ||
| Q2 25 | -0.2% | 4.3% | ||
| Q1 25 | -1.1% | 4.5% | ||
| Q4 24 | -1.0% | 10.0% | ||
| Q3 24 | -0.7% | 7.4% | ||
| Q2 24 | 1.4% | -2.5% | ||
| Q1 24 | -1.9% | -5.1% |
净利率EXPIPRGO
| Q4 25 | -1.1% | -127.8% | ||
| Q3 25 | 0.3% | 0.7% | ||
| Q2 25 | -0.2% | -0.8% | ||
| Q1 25 | -1.2% | -0.6% | ||
| Q4 24 | -0.9% | -3.9% | ||
| Q3 24 | -0.7% | -1.9% | ||
| Q2 24 | 1.0% | -10.2% | ||
| Q1 24 | -1.7% | 0.2% |
每股收益（稀释后）EXPIPRGO
| Q4 25 | $-0.08 | $-10.23 | ||
| Q3 25 | $0.02 | $0.05 | ||
| Q2 25 | $-0.01 | $-0.06 | ||
| Q1 25 | $-0.07 | $-0.05 | ||
| Q4 24 | $-0.06 | $-0.32 | ||
| Q3 24 | $-0.06 | $-0.15 | ||
| Q2 24 | $0.08 | $-0.79 | ||
| Q1 24 | $-0.10 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $124.2M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $242.8M | $2.9B |
| 总资产 | $442.5M | $8.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EXPIPRGO
| Q4 25 | $124.2M | — | ||
| Q3 25 | $112.8M | $432.1M | ||
| Q2 25 | $94.6M | $454.2M | ||
| Q1 25 | $115.7M | $409.9M | ||
| Q4 24 | $113.6M | $558.8M | ||
| Q3 24 | $130.4M | $1.5B | ||
| Q2 24 | $108.4M | $542.8M | ||
| Q1 24 | $109.2M | $658.5M |
股东权益EXPIPRGO
| Q4 25 | $242.8M | $2.9B | ||
| Q3 25 | $235.3M | $4.4B | ||
| Q2 25 | $218.4M | $4.5B | ||
| Q1 25 | $212.0M | $4.4B | ||
| Q4 24 | $204.9M | $4.3B | ||
| Q3 24 | $211.1M | $4.6B | ||
| Q2 24 | $220.3M | $4.5B | ||
| Q1 24 | $222.4M | $4.7B |
总资产EXPIPRGO
| Q4 25 | $442.5M | $8.5B | ||
| Q3 25 | $458.7M | $10.1B | ||
| Q2 25 | $481.2M | $10.1B | ||
| Q1 25 | $435.8M | $9.8B | ||
| Q4 24 | $390.7M | $9.6B | ||
| Q3 24 | $432.6M | $11.2B | ||
| Q2 24 | $457.4M | $10.4B | ||
| Q1 24 | $426.7M | $10.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.8M | $175.4M |
| 自由现金流经营现金流 - 资本支出 | $11.9M | $148.6M |
| 自由现金流率自由现金流/营收 | 1.0% | 13.4% |
| 资本支出强度资本支出/营收 | 0.2% | 2.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $109.0M | $145.1M |
8季度趋势，按日历期对齐
经营现金流EXPIPRGO
| Q4 25 | $13.8M | $175.4M | ||
| Q3 25 | $28.9M | $51.7M | ||
| Q2 25 | $36.1M | $75.9M | ||
| Q1 25 | $39.8M | $-64.5M | ||
| Q4 24 | $13.7M | $312.6M | ||
| Q3 24 | $46.0M | $42.2M | ||
| Q2 24 | $71.1M | $9.5M | ||
| Q1 24 | $60.7M | $-1.4M |
自由现金流EXPIPRGO
| Q4 25 | $11.9M | $148.6M | ||
| Q3 25 | $26.6M | $29.8M | ||
| Q2 25 | $33.3M | $56.7M | ||
| Q1 25 | $37.3M | $-90.0M | ||
| Q4 24 | $11.6M | $274.9M | ||
| Q3 24 | $44.4M | $15.1M | ||
| Q2 24 | $69.7M | $-18.9M | ||
| Q1 24 | $59.3M | $-26.5M |
自由现金流率EXPIPRGO
| Q4 25 | 1.0% | 13.4% | ||
| Q3 25 | 2.0% | 2.9% | ||
| Q2 25 | 2.5% | 5.4% | ||
| Q1 25 | 3.9% | -8.6% | ||
| Q4 24 | 1.1% | 24.2% | ||
| Q3 24 | 3.6% | 1.4% | ||
| Q2 24 | 5.4% | -1.8% | ||
| Q1 24 | 6.3% | -2.4% |
资本支出强度EXPIPRGO
| Q4 25 | 0.2% | 2.4% | ||
| Q3 25 | 0.2% | 2.1% | ||
| Q2 25 | 0.2% | 1.8% | ||
| Q1 25 | 0.3% | 2.4% | ||
| Q4 24 | 0.2% | 3.3% | ||
| Q3 24 | 0.1% | 2.5% | ||
| Q2 24 | 0.1% | 2.7% | ||
| Q1 24 | 0.1% | 2.3% |
现金转化率EXPIPRGO
| Q4 25 | — | — | ||
| Q3 25 | 8.26× | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.75× | — | ||
| Q1 24 | — | -0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXPI
| North American Realty | $1.1B | 96% |
| International Realty | $42.2M | 4% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
